Most importantly, survival rate of the mice receiving CAH (+) reached 83.33% without recurrence more than 300 days, which was significantly improved than that of the mice treated with PD‐1, DTIC and 5‐ALA (Figure 9G). The gene discussed is PDCD1; the disease is congenital adrenal hyperplasia.